Background: Bacteria responsible for causing lncisional Surgical Site Infection (ISSI) along with their resistance pattern changes over time due to various factors and are a matter of regular scrutiny. Proper understanding of this will help both surgeon and microbiologist to formulate an effective guideline to combat overall SSI.
Introduction
Staphylococcus aureus, Escherichia. coli, Pseudomonas spp. and Klebsiel/aspp. share the main culprits found to be causing 'Surgical Site Infection' (SSI) with their variable incidence and resistance pattern in different studies. 1 To add to their atrocity some of these micro bess howwavering multidrug resistance property. 2 Newer Cephalosporin, Quinolone and Carbapenemantibiotics are now a day used for prophylactic and therapeutic purposes to overcome this predicament. But this approach is not cost effective in developing countries. 3 Many a time patients fail to afford the cost of treatment due to poverty. So, treatment course remains incomplete leading to a chance of emerging resistance to that particular drug by those particular bacteria. This is rather a chronic situation: hence high magnitude of resistance is always a possibility. 2 Controversies exist about choice of antibiotics for prophylaxis and treatment of 'Surgical Site lnfection' 3 .Although patients present with a variety of sources of infections, every hospital should have antibiotic prophylaxis and therapeutic use protocol. Protocol must be reviewed and updated regularly. 4 Newer agents may become available that are more appropriate and more importantly, resistance pattern may change with time. 2 , 3 The aim of our study was to evaluate responsible microorganisms and their resistance pattern causing ISSI following elective gastrointestinal surgery in our context.
Methods
This observational study comprised of patients admitted and operated for different types of elective gastrointestinal surgery in the surgery department of Bangabandhu Seikh Mu jib Medical University during the period from January 2010 to June 2012 where purposive sampling technique was done. Out of 1122 patients having elective gastrointestinal surgery who developed lncisional Surgical Site Infection (183 cases) were included in the study. Patients having operation other than gastrointestinal tract, pediatric patients, patients with operations involving obviously infected wounds and those requiring more than one operation in the same admission were excluded.
Patients demographic and baseline variables were collected from all the patients by thorough history. Detailed clinical examination and baseline investigations and relevant investigations where necessary were done for diagnosis and assessment of general condition of the patients and fitness for general anesthesia.
Skin preparation consisted of shaving prior to surgery. Povidone Iodine solution was used as a pre-operative antiseptic skin preparation. Cloth drapes were standard and steridrapes were not used. After each operation a specific classification was ascertained to the surgical wound, using a standard classification system. In brief, dirty and contaminated wounds were considered to be those with gross contamination or spillage in the operative field, whereas clean-contaminated wounds were those that involved the surgical transaction of a nonsterilemucocutaneous surface. Antibiotic prophylaxis and use was according to the Judgment of the attending consultant surgeon. If unexpected problems were discovered at the time of surgery, they were indicated in the wound classification. Operated patients were followed up in the post operative period till discharge. All wounds were examined postoperatively. Those who developed wound complications after discharge and attended out-patient department within 30 days within surgery were evaluated.
During hospital stay according to CDC guideline Superficial Surgical Site Infection (SSSI) was assigned if it involved only the skin or subcutaneous tissue with at least one of the following criteria: purulent discharge with or without culture documentation, organisms isolated from fluid/tissue of the superficial incision, at least one sign of inflammation (e.g. pain or tenderness, indurations, erythema, local warmth of the wound) present, wound is deliberately opened by the surgeon and if the surgeon or clinician declares the wound infected. A wound was not considered a superficial lncisional SSI if a stitch abscess was present. Deep SSI was assigned if it involved deep soft tissues(e.g. fascia and/or muscle ) of the incision with at least one of the following criteria: purulent drainage present from the deep incision but without organ/space involvement, fascial dehiscence orfascia deliberately separated by the surgeon because of signs of inflammation, a deep abscess identified by direct examination or during reoperation, by histopathology, or by radiologic examination or if the surgeon or clinician declares that a deep lncisional infection is present.Specimens were obtained for culture from all lSSI and all isolates recovered were identified by standardized methods of culturing. Patient related data was collected using a structured research instrument ( data collection format) containing variables of interest. To be in attendance with methodology signs of wound infection with or without discharge and dehiscence were mostly noted between 5 th to 7 th postoperative days. Wound swab was taken from any wound fulfilling the criteria to be an ISSI and sent to microbiology department tor culture and sensitivity report. In this study 25.13 % cultures tailed to yield any growth of microorganism even with the presence other signs of ISSI (e.g. purulent discharge or tenderness, localized swelling, redness, heat etc.). It has been reported that presence of anaerobic bacteria, prior use of antibiotics which inhibited the growth of any bacteria in vitro culture might be the cause 13 , 14 .
Results:
It was observed that Escherichia coli (55.5%) was the most common organism isolated from ISSI followed by The resistance pattern was identified using the commonly used antibiotics. Escherichia coli was found resistant to Amoxicillin in 99% cases followed by Gentamycin in 58.5%, Ciprofloxacin in 41 %, Nitrofurantoin in 40% and Ceftriaxone in 22% cases. Siguan SS 18 in 1990 showed a lower resistance to Ampicillin (70%), Ciprofloxacin (0%) andGentamycin (50%), although a similar resistance was shown against Ceftriaxone (15%). This difference may be accredited to increased use of Ciprofloxacin and Gentamycinwith time. Miles TD et al. 19 showed in their study that Escherichia coli had lower resistance to Gentamycin (33.3%), Ciprofloxacin (10.4%) and Ampicillin (35.4%) compared to our study. Emerging resistance against Ceftriaxone is already an alarming issue that needs to be addressed avidly.Meropenem, a highly expensive carbapenem was 100% sensitive against all strains.
In case of Staphylococcus aureus, it is most resistant toAmoxicillin (87.5%), followed by Cloxacillin (62.5%), Gentamycin (50%), Ciprofloxacin (41.5%), Ceftriaxone (12.2%) and least resistant to Meropenem (0%). Siguan SS et al. 18 showed similar result to Ampicillin (95%) andCiprofloxacin (38%) but more resistance to Cloxacillin (100%) and Ceftriaxone (30%). In another study lkeagwu IJ et al. 20 showed a 63% resistance to Amoxicillin which is less than our study and 89% resistance to Cloxacillin which is more. The cause may be due to selection of sample although the trend is similar. Mannan 21 in his study showed 100% sensitivity to Cloxacillin which is completely opposite to our study picture. For Ciprofloxacin (11.5%) and Gentamycin (25%) resistance was quite lower.
Although he performed his study in one of the tertiary hospitals of Bangladesh the dissimilarity about sensitivity to Cloxacillin is significant and may be due to smaller study sample and use of different groups of antibiotic.
In this study Pseudomonas spp. 's remained resistant to Amoxicillin in all (100%) cases. Although it showed 50% resistance to Gentamycin and 51 % to Ciprofloxacin, Ceftriaxone is resistant in 35% cases.Surprisingly Pseudomonas spp. was 93.7% sensitive to Ceftazidime and no organism was resistant to Meropenem (0%). In a similar study Misra RN et al. 22 showed 88% resistance to Gentamycin and 53% resistance to Ciprofloxacin which is higher than our study. In another study by Pathmanathan SG et al. 23 Far-reaching in judicial exposure of these anti-microbial agents had been the cause behind the magnitude of this sort of resistance. 1 · 3 , 14 -24 In favor of this view Bachoualetal. 24 (1998) worked out the mutation of the resistance gene in Escherichia coli against fluoroquinolone. Although Gentamycin is cheap and in use for a long period, it still has variable but sometimes remarkable sensitivity pattern. The reason behind this may be due to lack of its oral preparation that to some extent limits its use.The increased resistance to Ciprofloxacin is alarming and in practice its use has already been abandoned in many cases. 25 Ceftriaxone now has become the first line of defense against ISSI.
Inept, reprehensible and random use of antibiotics leading to the development of a wide spectrum of resistant strainsof organisms will forcibly bound us to rely on expensive antibiotics if proper precaution is not accepted and a guideline not formulated and followed at once." 25 We should by no means allow the resistance pattern for newer antimicrobials' like 
